Because obesity is a state of diminished spontaneous and stimulated GH secretion (33, 34), it has been proposed that NAFLD in obesity has similar mechanisms to that observed in the animal models of decreased GH signaling in liver (13, 16). This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.